Bill Snyder Archive — Page 110 of 121
-
August 15, 2013
$5.2M NIH grant bolsters colorectal cancer research
Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer. -
August 15, 2013
Transplant drug added to PREDICT program
Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection. -
August 14, 2013
Oxidative stress in autism
A biomarker for oxidative stress is elevated in patients with both autism spectrum disorder and gastrointestinal dysfunction, suggesting opportunities for individualized approaches to clinical care. -
August 8, 2013
Nuclear shield against cell death
The protein SARM appears to protect cells from inflammation-driven death by stabilizing the nuclear laminin scaffold. -
August 5, 2013
Vanderbilt scientists discover potential new way to treat anxiety
Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural “endocannabinoids” without gastrointestinal side effects, Vanderbilt University scientists will report next week. -
July 18, 2013
Data management tool developed at VU sees global growth
The number of researchers and institutions worldwide using a Vanderbilt University-developed Web application to collect and manage their data has about doubled in the past year.